Business Update
Covalent Group announces results of shareholder vote
Published in Cardiovascular Business Week, November 21st, 2006
Covalent Group, Inc. (CVGR), providing design, development, and management of complex clinical trials and patient registries for many of the world's leading pharmaceutical and biotechnology companies, announced that its shareholders have approved all seven proposals contained in its 2006 proxy, including the issuance of additional shares of Covalent common stock in connection with the consummation of the business combination agreement with Remedium Oy, a privately owned, full-service contract research organization (CRO) based in Espoo, Finland.
The vote to approve the issuance of the additional shares took place at the company's annual meeting in Wayne, Pennsylvania....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Abdominal Aortic Aneurysms
Endologix announces favorable Powerlink five-year follow-up data at TCT 2006 Conference - Antibacterial Agents
Pneumonia germ cell wall can damage heart, brain cells - Business & Finance
Cholestech increases revenue 12% in second quarter of fiscal 2007 - Business & Finance
Cytokinetics reports third quarter 2006 financial results and clinical highlights - Business & Finance
Edwards Lifesciences reports solid third quarter earnings - Business Update
Datascope to exit vascular closure market, phase out interventional products business - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
